Wound Treatments in Vietnam

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN VIETNAM
• Executive Summary
• Stable Growth Due To Improved Living Standards
• Foreign Companies Dominate
• Accession To the Wto To Attract More Competition
• Stricter Government Control on Price
• Potential for Strong Growth Due To Large Population
• Key Trends and Developments
• Improved Economy Boosts Demand
• Open Economy Attracts More Foreign Players
• Price Becomes More Stable
• Local Firms Improve Share by Improving Product Quality
• Herbal Medicine Receives More Attention
• Chemists/pharmacies Remains the Key Distribution Channel
• Appendix
• OTC Registration and Classification
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Market Indicators
  • Table 1 Life Expectancy at Birth 2001-2006
• Market Data
  • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
  • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
  • Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
  • Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
  • Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
  • Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
• Appendix
• Consumer Expenditure on Health Goods and Medical Services
  • Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
• Definitions
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - VIETNAM
• Domesco - Dongthap Medical Import Export Corp
• Strategic Direction
• Key Facts
  • Summary 2 Domesco - Dongthap Medical Import Export Corp: Key Facts
  • Summary 3 Domesco - Dongthap Medical Import Export Corp: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 4 Domesco - Dongthap Medical Import Export Corp: Competitive Position 2006
• Haugiang Pharmaceutical Joint Stock Co
• Strategic Direction
• Key Facts
  • Summary 5 Haugiang Pharmaceutical Joint Stock Co: Key Facts
  • Summary 6 Haugiang Pharmaceutical Joint Stock Co: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 7 Haugiang Pharmaceutical Joint Stock Co: Competitive Position 2006
• Ica Pharmaceuticals
• Strategic Direction
• Key Facts
  • Summary 8 ICA Pharmaceuticals: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 9 ICA Pharmaceuticals: Competitive Position 2006
• Opc - National Pharmaceutical Enterprise No 26
• Strategic Direction
• Key Facts
  • Summary 10 OPC - National Pharmaceutical Enterprise No 26: Key Facts
  • Summary 11 OPC - National Pharmaceutical Enterprise No 26: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 12 OPC - National Pharmaceutical Enterprise No 26: Competitive Position 2006
• Traphaco
• Strategic Direction
• Key Facts
  • Summary 13 Traphaco: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 14 Traphaco: Competitive Position 2006
• WOUND TREATMENTS IN VIETNAM
• Overview
• Sector Data
  • Table 11 Sales of Wound Treatments by Subsector: Value 2001-2006
  • Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
  • Table 13 Wound Treatments Company Shares by Retail Value 2002-2006
  • Table 14 Wound Treatments Brand Shares by Retail Value 2003-2006
  • Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
  • Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
• Wound treatments Vietnam